In 2016, Fresenius Kabi elected to expand their Melrose Park facility with a $250 million investment towards a state-of-the-art sterile injectable pharmaceuticals manufacturing plant.
Project Start: September 2017
Project Completion: 2026
General Contractor: Gilbane Building Company
